The human genome scientists use to scout for disease just got a major makeover

The human genome scientists use to scout for disease just got a major makeover


Andrew Brookes | Image Source | Getty Images

Scientists have been using the same human genome sequence to study genomics for more than 20 years, but on Wednesday it got a major makeover.

Researchers published a new, more inclusive collection of reference human genome sequences in a landmark development that greatly expands on that original reference sequence.

The new pangenome reference includes genome sequences of 47 people from across the globe, according to a series of peer-reviewed papers published in the journal Nature on Wednesday. The original reference human genome sequence primarily came from one person, though it includes components from a total of around 20 people.

The pangenome better reflects the global gene pool, so scientists will be able to use it to more accurately identify genetic variations related to disease. The more diverse reference map will also eventually be used to help develop more personalized care that is tailored to an individual’s DNA, according to the researchers.

A genome is the complete set of DNA instructions necessary for an organism to grow and function. Scientists rely on a reference human genome to establish a “standard” they can use to study the variations that make people unique. On average, human beings’ genomes are around 99% identical, but small differences can give scientists insights into the traits that could affect an individual’s health. 

 “With a pangenome reference, we can accelerate clinical research by improving our understanding of the link between genes and disease traits,” Wen-Wei Liao, co-first author of the paper, said in a release. 

The pangenome uses advanced computational techniques to align all the genome sequences. These techniques helped fill in gaps left by the original reference by adding more than 100 million new DNA letters, the release said.  

“The human pangenome reference will enable us to represent tens of thousands of novel genomic variants in regions of the genome that were previously inaccessible,” Liao said. 

Scientists at the Human Pangenome Reference Consortium, which is funded by part of the National Institutes of Health, conducted the research.



Source

Trump signs executive order reclassifying cannabis, opening door to broader weed access
Health

Trump signs executive order reclassifying cannabis, opening door to broader weed access

U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C., U.S., Dec. 18, 2025. Evelyn Hockstein | Reuters President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug and marking the most consequential shift in […]

Read More
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 
Health

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s injection Zepbound and Novo Nordisk’s rival shot Wegovy in a late-stage trial.  The company also said it has filed for Food and Drug Administration approval of the daily […]

Read More
Medical supply firm Medline set to debut after biggest IPO of 2025
Health

Medical supply firm Medline set to debut after biggest IPO of 2025

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year.  The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the […]

Read More